Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Fever × Meropenem × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Febrile Neutropenia 5 Neoplasms 3 Urinary Bladder Neoplasms 1 Sepsis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Other Infectious Diseases 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Fever 1 Emergencies 1

Interventions

Vancomycin 4 pegfilgrastim 3 Cefepime 3 trametinib 2 dabrafenib 2 Piperacillin, Tazobactam Drug Combination 2 Filgrastim 2 Ciprofloxacin 2 Ceftazidime 2 ofatumumab 1 liposomal amphotericin B 1 ceftobiprole medocaril 1 Teicoplanin 1 Tazobactam 1 Surveys and Questionnaires 1 Ritonavir 1 Quality of Life 1 Povidone-Iodine 1 Piperacillin 1 Moxifloxacin 1 Metformin 1 Meropenem 1 Mannose-Binding Lectin 1 Levofloxacin 1 Lenalidomide 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Granulocyte Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02463747 2015-06-04

RR

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown

Classical hematology

Fever, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡